Ratings by Truist Securities (Joon Lee)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/31/2025 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 12/31/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/30/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2025 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2025 | Alkermes | ALKS | New Coverage | Buy (N/A) |
32.65 (28.63) |
-12.31% | Details | |
| 11/10/2025 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2025 | Adverum Biotechnologies | ADVM | Downgrade | Hold (Buy) |
4.18 (4.36) |
4.31% | Details | |
| 10/16/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2025 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2025 | Rapport Therapeutics | RAPP | New Coverage | Buy (N/A) |
24.73 (30.24) |
22.28% | Details | |
| 8/28/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2025 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Larimar Therapeutics | LRMR | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Intellia Therapeutics | NTLA | Maintain | (N/A) |
|
Details | ||
| 8/8/2025 | CRISPR Therapeutics | CRSP | Maintain | (N/A) |
|
Details | ||
| 8/5/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2025 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2025 | Verona Pharma | VRNA | Downgrade | Hold (Buy) |
86.86 (106.91) |
23.08% | Details | |
| 6/26/2025 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2025 | Sage Therapeutics | SAGE | Maintain | Hold (N/A) |
|
Details | ||
| 6/17/2025 | PTC Therapeutics | PTCT | New Coverage | Buy (N/A) |
51.87 (62.82) |
21.11% | Details | |
| 5/22/2025 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2025 | Solid Biosciences | SLDB | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2025 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2025 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2025 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2025 | Voyager Therapeutics | VYGR | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2025 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2025 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2025 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2025 | Larimar Therapeutics | LRMR | New Coverage | Buy (N/A) |
3.48 (5.22) |
50% | Details | |
| 1/21/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Solid Biosciences | SLDB | New Coverage | Buy (N/A) |
3.92 (6.75) |
72.19% | Details | |
| 12/23/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2024 | Editas Medicine | EDIT | Downgrade | Hold (Buy) |
1.99 (2.00) |
0.5% | Details | |
| 11/12/2024 | Axsome Therapeutics | AXSM | Maintain | Buy (Buy) |
|
Details | ||
| 11/11/2024 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2024 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2024 | Editas Medicine | EDIT | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2024 | Sage Therapeutics | SAGE | Maintain | Hold (N/A) |
|
Details | ||
| 10/24/2024 | Marinus Pharmaceuticals | MRNS | Downgrade | Hold (Buy) |
1.69 (0.55) |
-67.46% | Details | |
| 10/22/2024 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2024 | Corcept Therapeutics | CORT | Maintain | Buy (Buy) |
|
Details | ||
| 10/15/2024 | Longboard Pharmaceuticals Inc | LBPH | Downgrade | Hold (Buy) |
38.90 (59.98) |
54.19% | Details | |
| 10/9/2024 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2024 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2024 | Voyager Therapeutics | VYGR | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2024 | Longboard Pharmaceuticals Inc | LBPH | New Coverage | Buy (N/A) |
34.51 (59.98) |
73.8% | Details | |
| 9/5/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Sage Therapeutics | SAGE | Maintain | Hold (N/A) |
|
Details | ||
| 8/13/2024 | Adverum Biotechnologies | ADVM | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2024 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Editas Medicine | EDIT | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2024 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2024 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2024 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2024 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2024 | Sage Therapeutics | SAGE | Maintain | Hold (N/A) |
|
Details | ||
| 4/17/2024 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2024 | Sage Therapeutics | SAGE | Maintain | Hold (N/A) |
|
Details | ||
| 4/16/2024 | Vertex | VRTX | New Coverage | Buy (N/A) |
396.55 (456.69) |
15.17% | Details | |
| 4/16/2024 | BioMarin Pharmaceutical Inc. | BMRN | New Coverage | Buy (N/A) |
92.22 (61.12) |
-33.72% | Details | |
| 3/5/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2024 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2024 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2024 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2024 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2024 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2024 | Sage Therapeutics | SAGE | Maintain | Hold (N/A) |
|
Details | ||
| 1/3/2024 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2023 | Editas Medicine | EDIT | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2023 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Corcept Therapeutics | CORT | Downgrade | Hold (Buy) |
25.62 (33.87) |
32.2% | Details | |
| 10/27/2023 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2023 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2023 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Buy (N/A) |
1.42 (310.71) |
21780.99% | Details | |
| 8/14/2023 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Sage Therapeutics | SAGE | Maintain | Hold (N/A) |
|
Details | ||
| 8/2/2023 | Corcept Therapeutics | CORT | Maintain | Hold (N/A) |
|
Details | ||
| 7/27/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/20/2023 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2023 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2023 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2023 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | Voyager Therapeutics | VYGR | New Coverage | Buy (N/A) |
10.76 (3.90) |
-63.75% | Details | |
| 5/5/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2023 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | Viking Therapeutic | VKTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/1/2023 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 1/19/2023 | Concert Pharmaceuticals | CNCE | Downgrade | Hold (Buy) |
6.90 (8.37) |
21.3% | Details | |
| 1/19/2023 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2023 | Editas Medicine | EDIT | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2023 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2022 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2022 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Relmada Therapeutics Inc | RLMD | Maintain | Hold (N/A) |
|
Details | ||
| 11/23/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Relmada Therapeutics Inc | RLMD | Maintain | Hold (N/A) |
|
Details | ||
| 11/3/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2022 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2022 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2022 | Relmada Therapeutics Inc | RLMD | New Coverage | Hold (Buy) |
6.47 (4.45) |
-31.22% | Details | |
| 9/13/2022 | Concert Pharmaceuticals | CNCE | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2022 | Aptinyx | APTX | Downgrade | Hold (Buy) |
0.41 (0.06) |
-85.37% | Details | |
| 8/12/2022 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2022 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2022 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Global Blood Therapeutics | GBT | Downgrade | Hold (Buy) |
63.84 (68.49) |
7.28% | Details | |
| 7/28/2022 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (Buy) |
|
Details | ||
| 7/14/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (Buy) |
|
Details | ||
| 7/7/2022 | Adverum Biotechnologies | ADVM | Upgrade | Buy (Hold) |
1.23 (4.36) |
254.47% | Details | |
| 6/22/2022 | Verona Pharma | VRNA | Maintain | Buy (Buy) |
|
Details | ||
| 5/31/2022 | Adverum Biotechnologies | ADVM | Maintain | Hold (N/A) |
|
Details | ||
| 5/16/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (Buy) |
|
Details | ||
| 5/5/2022 | Cyclerion Therapeutics | CYCN | Maintain | Buy (Buy) |
|
Details | ||
| 5/3/2022 | Verona Pharma | VRNA | Maintain | Buy (Buy) |
|
Details | ||
| 4/28/2022 | Viking Therapeutic | VKTX | Maintain | Buy (Buy) |
|
Details | ||
| 4/7/2022 | Aptinyx | APTX | Maintain | Buy (Buy) |
|
Details | ||
| 4/1/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2022 | Aptinyx | APTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/22/2022 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 3/21/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (Buy) |
|
Details | ||
| 3/18/2022 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (Buy) |
|
Details | ||
| 3/8/2022 | Sage Therapeutics | SAGE | Maintain | Hold (Hold) |
|
Details | ||
| 3/3/2022 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2022 | CorMedix | CRMD | Maintain | Buy (Buy) |
|
Details | ||
| 2/23/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (Buy) |
|
Details | ||
| 2/18/2022 | Arvinas Inc. | ARVN | Maintain | Buy (Buy) |
|
Details | ||
| 2/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Buy (Buy) |
|
Details | ||
| 2/15/2022 | Intellia Therapeutics | NTLA | Maintain | Buy (Buy) |
|
Details | ||
| 2/11/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (Buy) |
|
Details | ||
| 2/10/2022 | Aptinyx | APTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/10/2022 | Viking Therapeutic | VKTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/7/2022 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (Buy) |
|
Details | ||
| 2/3/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (Buy) |
|
Details | ||
| 2/3/2022 | Intellia Therapeutics | NTLA | Maintain | Buy (Buy) |
|
Details | ||
| 1/27/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (Buy) |
|
Details | ||
| 1/24/2022 | Viking Therapeutic | VKTX | Maintain | Buy (Buy) |
|
Details | ||
| 1/14/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (Buy) |
|
Details | ||
| 12/20/2021 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 11/11/2021 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2021 | Cyclerion Therapeutics | CYCN | New Coverage | Buy (N/A) |
2.66 (1.41) |
-46.99% | Details | |
| 10/13/2021 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2021 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2021 | Adverum Biotechnologies | ADVM | Maintain | Hold (N/A) |
|
Details | ||
| 8/9/2021 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Editas Medicine | EDIT | Upgrade | Buy (Hold) |
55.59 (1.99) |
-96.42% | Details | |
| 8/4/2021 | Global Blood Therapeutics | GBT | Upgrade | Buy (Hold) |
27.75 (68.49) |
146.81% | Details | |
| 7/27/2021 | Relmada Therapeutics Inc | RLMD | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2021 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2021 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2021 | Taysha Gene Therapies | TSHA | New Coverage | Buy (N/A) |
25.14 (4.57) |
-81.82% | Details | |
| 4/29/2021 | Adverum Biotechnologies | ADVM | Downgrade | Hold (Buy) |
10.16 (4.36) |
-57.09% | Details | |
| 4/21/2021 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
61.91 (7.23) |
-88.32% | Details | |
| 3/18/2021 | Translate Bio | TBIO | Downgrade | Hold (Buy) |
25.02 (3.23) |
-87.09% | Details | |
| 3/2/2021 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2021 | Editas Medicine | EDIT | Downgrade | Hold (Buy) |
44.76 (2.00) |
-95.53% | Details | |
| 12/2/2020 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2020 | Marinus Pharmaceuticals | MRNS | New Coverage | Buy (N/A) |
11.62 (1.69) |
-85.46% | Details | |
| 9/21/2020 | CorMedix | CRMD | New Coverage | Buy (N/A) |
4.61 (6.46) |
40.13% | Details | |
| 8/12/2020 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Buy (N/A) |
|
Details |
